| Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stock futures fell on Monday after all three major indexes turned in their worst week in three months. Investors are preparing for the Federal Reserve's two-day policy meeting on Sept. 20-21. The central bank will likely deliver a third-straight 75-basis-point increase. When markets are falling, it's vital you know how to make money regardless of a stock's direction. That's why we're focusing on 'The Perfect Timing Pattern' in The War Room. This is a simple pattern you can learn in just one day that's helping investors weather the 2022 Wall Street storm. Click here to learn about 'The Perfect Timing Pattern.' Here's a look at the top-moving stocks this morning. Bluebird Bio (Nasdaq: BLUE) Bluebird Bio is up 14.51% premarket after the biotech company netted a second key win from the U.S. Food and Drug Administration. The FDA approved bluebird's gene tehrapy eli-cel, which is designed to treat boys ages 4-17 with the neurological disorder cerebral adrenoleukodystrophy. The drug has a wholesale cost of $3 million, according to the company. Medical technology has come a long way, and there are so many buying opportunities to be had in this sector. Our friend Alexander Green is high on one particular company. He's calling this technology "the most incredible investment opportunity in 37 years." Click here to unlock this $3 stock. VEON (Nasdaq: VEON) VEON is up 11.08% premarket after the company continues its operational momentum. Service revenue increased 4.3%, with five of seven countries reporting double-digit local currency revenue growth for the period. VEON is a telecommunications company that operates predominantly in Asia, Africa and Europe. | 
No comments:
Post a Comment